Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D I Watkins

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Virology|August 10, 1999
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenT Hanke, R V Samuel, T J Blanchard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2J A Urvater, H Hickman, J L Dzuris, et al.
Immunogenetics|August 7, 2001
A common rhesus macaque MHC class I molecule which binds a cytotoxic T-lymphocyte epitope in Nef of simian immunodeficiency virusH Horton, W Rehrauer, E C Meek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimenT M Allen, T U Vogel, D H Fuller, et al.
Journal of Virology|January 3, 2001
CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testingT M Allen, B R Mothé, J Sidney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimenZ Hel, W P Tsai, A Thornton, et al.
Nature Medicine|December 1, 2001
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaquesI M Belyakov, Z Hel, B Kelsall, et al.
Journal of Virology|July 25, 2000
Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progressionD T Evans, P Jing, T M Allen, et al.
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
Nature Medicine|November 5, 1999
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and NefD T Evans, D H O'Connor, P Jing, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Virology|August 10, 1999
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenT Hanke, R V Samuel, T J Blanchard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2J A Urvater, H Hickman, J L Dzuris, et al.
Immunogenetics|August 7, 2001
A common rhesus macaque MHC class I molecule which binds a cytotoxic T-lymphocyte epitope in Nef of simian immunodeficiency virusH Horton, W Rehrauer, E C Meek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimenT M Allen, T U Vogel, D H Fuller, et al.
Journal of Virology|January 3, 2001
CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testingT M Allen, B R Mothé, J Sidney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimenZ Hel, W P Tsai, A Thornton, et al.
Nature Medicine|December 1, 2001
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaquesI M Belyakov, Z Hel, B Kelsall, et al.
Journal of Virology|July 25, 2000
Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progressionD T Evans, P Jing, T M Allen, et al.
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
Nature Medicine|November 5, 1999
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and NefD T Evans, D H O'Connor, P Jing, et al.
Pageof 11